TD SYNNEX is in a powerful, sustained uptrend: the stock is up 61.2% over the past year and 61.2% year-to-date, vastly outpacing the S&P 500's 13.1% and 11.5% respective gains, with relative strength of +48.1% over one year. At $247.34, the shares sit roughly 17.2% below the 52-week high of $298.77 and about 73.9% above the 52-week low of $142.22 — positioning the stock at approximately 66% of its 52-week range, which signals a healthy but no longer overextended uptrend after a sharp autumn pullback. The stock is consolidating in the upper-middle of its range rather than pressing highs, suggesting momentum has cooled from euphoric levels while the longer-term trend structure remains intact.

Short-term momentum has clearly decelerated and diverged from the annual trend: the stock is down 14.1% over the past month versus a 1.0% decline in SPY, producing a relative strength reading of -13.1% for one month, even as the 3-month change is a modest +1.8% and the 6-month change is +8.6%. This divergence — a strong 1-year trend colliding with a sharp 1-month drawdown — reflects a mean-reversion pullback from the September peak near $287.89 (and the 52-week high of $298.77), likely profit-taking after a parabolic June–September run rather than a confirmed trend reversal, given the stock has stabilized in the $246–$251 zone over the past several sessions. Volume of roughly 710,000 shares and a short ratio of 1.76 indicate no aggressive bearish positioning, while the -18.77% max drawdown underscores that this name can correct sharply even within a bull phase.

Key technical levels are well defined: support sits at the recent October low around $246.75, with the 52-week low of $142.22 as the ultimate floor, while resistance lies at the September high near $287.89 and the 52-week high of $298.77. A breakout above $298.77 would confirm resumption of the primary uptrend and likely open a test of the $300+ round-number zone, whereas a decisive breakdown below $246 would signal a deeper correction toward the $230s and undermine the bullish structure. With a beta of 1.371, the stock is roughly 37% more volatile than the market, meaning position sizing should account for amplified drawdowns — a 1.37 beta implies the stock would be expected to fall about 37% more than SPY in a broad market selloff, reinforcing the need for disciplined stop levels around the $246 support.

Revenue growth has reaccelerated dramatically: Q3 FY26 revenue reached $21.56 billion, up 37.8% year over year from $15.65 billion in Q3 FY25, following sequential quarterly revenue of $19.57 billion in Q2 FY26 and $17.16 billion in Q1 FY26 — a clear acceleration from the roughly $17.4 billion reported in Q4 FY25. The product segment dominates at $6.12 billion (reported segment basis) versus $1.30 billion in services, meaning the AI-driven hardware cycle is the primary growth engine, while the higher-margin services line remains a smaller but strategically important contributor. This trajectory implies the investment case is now a cyclical-growth story tied to AI infrastructure demand rather than the low-single-digit steady-state distributor model investors historically priced in, though the sustainability of such a steep growth rate into FY27 is the central question.

The company is solidly profitable but operates on thin margins typical of IT distribution: Q3 FY26 net income was $416.2 million on $21.56 billion of revenue (1.93% net margin), with gross margin of 6.61% and operating margin of 2.98%. Margins have been compressing modestly over recent quarters — gross margin fell from 7.30% in Q1 FY26 to 6.84% in Q2 and 6.61% in Q3 — as the revenue mix shifted toward lower-margin hardware and AI infrastructure, even as absolute gross profit rose from $1.25 billion to $1.43 billion. Net income nonetheless grew sequentially from $326.9 million to $334.1 million to $416.2 million, and EPS rose from $4.04 to $4.15 to $5.18, showing that operating leverage and volume are more than offsetting the margin dilution — but the sub-7% gross margin leaves little cushion if pricing pressure intensifies.

Balance-sheet and cash-flow metrics reveal the key risk: free cash flow TTM is -$815.0 million, with operating cash flow of -$916.7 million in Q3 FY26 alone as inventory swelled by $1.42 billion and receivables by $2.07 billion to fund the growth surge. The debt-to-equity ratio of 0.546 and current ratio of 1.21 are manageable, and ROE of 9.79% and ROA of 3.50% are respectable for a distributor, but the negative FCF yield (price-to-free-cash-flow ratio of -20.5x on a trailing basis) means the company is currently dependent on working-capital financing and its balance sheet rather than internal cash generation. The interest coverage ratio of 5.33x and interest expense of $120.5 million in Q3 provide adequate but not generous cushion; investors should watch for a working-capital reversal in coming quarters, which historically has converted to strong positive FCF (e.g., +$1.42 billion in Q4 FY25) and would materially de-risk the story.